VERICEL CORPORATION - COMMON STOCK
59.11
22-November-24 15:44:58
15 minutes delayed
Stocks
+2.40
+4.23%
Today's range
56.52 - 60.16
ISIN
N/A
Source
NASDAQ
-
Vericel to Report Third-Quarter 2021 Financial Results on November 9, 2021
21 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
08 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
07 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vericel Reports Second Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
04 Aug 2021 07:00:03 By Nasdaq GlobeNewswire
-
Vericel to Report Second-Quarter 2021 Financial Results on August 4, 2021
21 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vericel to Present at the Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021
07 Jul 2021 07:30:01 By Nasdaq GlobeNewswire
-
Vericel Provides Regulatory Update for NexoBrid
29 Jun 2021 07:45:00 By Nasdaq GlobeNewswire
-
09 Jun 2021 08:00:01 By Nasdaq GlobeNewswire
-
Vericel Announces Appointment of Lisa Wright to Board of Directors
02 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
13 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
05 May 2021 06:00:01 By Nasdaq GlobeNewswire
-
Vericel to Report First-Quarter 2021 Financial Results on May 5, 2021
21 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
09 Apr 2021 08:24:54 By Nasdaq GlobeNewswire
-
Vericel to Present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021
10 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
02 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
24 Feb 2021 07:00:02 By Nasdaq GlobeNewswire
-
22 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
16 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vericel Announces Termination of Shareholder Rights Agreement
12 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vericel to Report Fourth-Quarter 2020 Financial Results on February 24, 2021
10 Feb 2021 07:00:02 By Nasdaq GlobeNewswire